Chips · Stock report · Aehr Test Systems (NASDAQ: AEHR)
Aehr — 79th of 86 chip stocks over one month, despite a 26.5% one-day jump
The Closelooknet read
Aehr Test Systems (NASDAQ: AEHR) ranks 79th of the 86 chip stocks in our section on one-month move at -37.6%, even after it jumped 26.5% on 3 November. Our money-flow reading (a gauge of net buying pressure) stands at 114.9, still positive but slowing, after falling 69.3 points over 21 sessions. Our composite score is 34 of 100. What we watch: whether the close of $65.11 holds and moves back toward the 50-day average at $82.04, or slips back under the day's starting level.
Where Aehr stands among our chip stocks
Aehr's one-month move of -37.6% puts it 79th of 86 in our chip section. The weakness is wide in its testing and metrology group: Teradyne (TER) is down 39.4% over the month, Onto Innovation (ONTO) 37.8%, FormFactor (FORM) 34.6% and Ferrotec Holdings (6890.T) 32.2%.
Advantest (6857.T) and Lasertec (6920.T) held up better: Advantest is down 4.9% and Lasertec 10.9%. Technoprobe (TPRO.MI) is down 27.8% over the month. Aehr is 55.3% below its 52-week closing high of $145.61 from 17 August.
Our money-flow and quality readings
Our money-flow reading for Aehr is 114.9, labelled "warm" (our label for the strength of net buying). It is still positive but slowing: it fell 69.3 points over 21 sessions.
Our composite score is 34. The balance sheet scores 96, but growth is 30, momentum 27, valuation 26, capital allocation 21, cash quality 19 and quality 15. The Piotroski score, a check of financial health, is scored 2 of 8.
Price trend
Aehr closed at $65.11 on 3 November after opening with a 10.8% gap up. The move was 3.97 times its typical daily swing of about 6.7%.
The stock sits 20.6% below its 50-day average of $82.04 and 12.9% below the average close of the last 200 sessions, $74.71. It is still up 222.5% this year and 150.5% over twelve months, and 235.6% above its 52-week closing low of $19.40 from 20 November 2025.
Closelooknet is a research diary. Nothing here is investment advice or a recommendation to buy or sell.